CRH (NYSE: CRH) strategy chief receives share awards, tax sale reported

Rhea-AI Filing Summary

CRH plc Chief Strategy Officer Juan Pablo San Agustin reported multiple equity award transactions. On February 24, 2026, he acquired 4,119 Deferred Share Awards through an exercise of derivative securities and received a grant of 27,293 Ordinary Shares, tied to performance-based awards granted in 2023.

He also acquired 4,422 Ordinary Shares from the vesting of a time-based deferred share award. To cover related withholding tax liabilities, there was a mandatory sale of 15,344 Ordinary Shares at a volume‑weighted average price of $121.8059, with sale prices ranging from $120.15 to $122.82. On February 23, 2026, he was granted 6,920 Restricted Share Units, each representing one Ordinary Share and vesting in three equal annual installments beginning in February 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

San Agustin Juan Pablo

(Last) (First) (Middle)

C/O CRH PLC

STONEMASON'S WAY

(Street)

RATHFARNHAM DUBLIN L2 D16 KH51

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CRH PUBLIC LTD CO [ CRH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Strategy Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/24/2026		A		27,293(1)	A	$0	60,021	D
Ordinary Shares	02/24/2026		M		4,422(2)	A	$0	64,443	D
Ordinary Shares	02/24/2026		F		15,344(3)	D	$121.8059(4)	49,099	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Awards	(2)	02/24/2026		M			4,119(2)	(2)	(2)	Ordinary Shares	4,119	(2)	5,052	D
Restricted Share Units	(5)	02/23/2026		A		6,920(5)		(5)	(5)	Ordinary Shares	6,920	(5)	15,044	D

Explanation of Responses:

1. Reflects the vesting and release of awards granted in 2023 under the 2014 Performance Share Plan Rules on February 24, 2026 (including the award of 1,865 additional Ordinary Shares as dividend equivalents), pursuant to certification of the achievement of pre-established performance goals by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee").

2. Reflects the vesting and release of a time-based conditional award as defined in the 2014 Deferred Share Bonus Plan (the "DSB Plan Rules"), of which, pursuant to the determination of the Compensation Committee, a total of 4,422 shares vested on February 23, 2026, including the award of 303 additional Ordinary Shares as dividend equivalents.

3. Mandatory sale of sufficient Ordinary Shares to cover applicable withholding tax liabilities arising in the connection with the aforementioned awards.

4. The reported price represents the volume-weighted average price of shares sold. Sale prices for the reported transaction ranged between $120.15 and $122.82, inclusive. Full information regarding the Ordinary Shares sold will be provided to the SEC upon request.

5. Each restricted share unit ("RSU") represents the right to receive one Ordinary Share of the Issuer. Reflects a time-based conditional award, as defined in the CRH plc Equity Incentive Plan (the "EIP"), of RSUs of which 1/3 will vest on the grant anniversary in February 2027,2028 and 2029, respectively (the "Awards"). In accordance with the EIP, dividend equivalents will apply to these Awards and will be reported at the time of vesting.

	/s/ Cot Eversole, Attorney-in-Fact for Juan Pablo San Agustin	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did CRH (CRH) report for Juan Pablo San Agustin?

CRH reported that Chief Strategy Officer Juan Pablo San Agustin received vested share awards and new grants, plus a mandatory sale of shares to cover tax withholding obligations, all occurring on February 23 and 24, 2026 under existing company equity plans.

How many CRH ordinary shares did the officer acquire in these Form 4 transactions?

He acquired 27,293 Ordinary Shares from a 2023 performance-based award and 4,422 Ordinary Shares from a time-based deferred award, both vesting in February 2026, increasing his directly held Ordinary Shares before tax withholding-related sales.

Why were 15,344 CRH ordinary shares sold and at what prices?

A total of 15,344 Ordinary Shares were mandatorily sold to cover applicable withholding tax liabilities arising from the equity awards. The volume‑weighted average sale price was $121.8059, with individual sale prices ranging between $120.15 and $122.82, inclusive.

What new Restricted Share Units did CRH grant to its Chief Strategy Officer?

CRH granted 6,920 Restricted Share Units on February 23, 2026. Each RSU represents one Ordinary Share, with one‑third scheduled to vest on each grant anniversary in February 2027, 2028, and 2029, and dividend equivalents to be reported at vesting.

What plans governed the CRH equity awards reported in this Form 4?

The transactions reflect awards under several CRH plans: the 2014 Performance Share Plan Rules, the 2014 Deferred Share Bonus Plan, and the CRH plc Equity Incentive Plan, as referenced in the footnotes describing vesting conditions and dividend equivalents.